Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wilmott

Showing results (31-40 of 162) with videos related to

Pageof 17
Sort By:
Annals of Surgical Oncology|May 21, 2015
Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastasesLodewijka H J Holtkamp, Shu Wang, James S Wilmott, et al.
Pathology|June 6, 2021
Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysisStuart J Gallagher, Teresa Bailey, Robert V Rawson, et al.
Dermatologic Therapy|March 29, 2022
Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metastatic melanoma: Pathogenesis, immunohistochemical analysis and treatmentPhoebe Star, Louise A Jackett, Karen Cheung, et al.
Pathology|August 20, 2022
Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimicsRobert V Rawson, Eva R Shteinman, Sameera Ansar, et al.
The American Journal of Surgical Pathology|November 20, 2019
Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in PregnancyLouise A Jackett, Andrew J Colebatch, Robert V Rawson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 26, 2015
Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastasesHojabr Kakavand, Ricardo E Vilain, James S Wilmott, et al.
The American Journal of Surgical Pathology|December 17, 2013
Intrapatient homogeneity of BRAFV600E expression in melanomaAlexander M Menzies, Trina Lum, James S Wilmott, et al.
Pathology|March 12, 2014
Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomasHojabr Kakavand, Oana Crainic, Trina Lum, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 4, 2015
Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanomaJames S Wilmott, Andrew J Colebatch, Hojabr Kakavand, et al.
The American Journal of Surgical Pathology|October 3, 2012
Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanomaGeorgina V Long, James S Wilmott, David Capper, et al.
Pageof 17

Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Annals of Surgical Oncology|May 21, 2015
Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastasesLodewijka H J Holtkamp, Shu Wang, James S Wilmott, et al.
Pathology|June 6, 2021
Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysisStuart J Gallagher, Teresa Bailey, Robert V Rawson, et al.
Dermatologic Therapy|March 29, 2022
Multiple eruptive squamoproliferative lesions during anti-PD1 immunotherapy for metastatic melanoma: Pathogenesis, immunohistochemical analysis and treatmentPhoebe Star, Louise A Jackett, Karen Cheung, et al.
Pathology|August 20, 2022
Diagnostic utility of PRAME, p53 and 5-hmC immunostaining for distinguishing melanomas from naevi, neurofibromas, scars and other histological mimicsRobert V Rawson, Eva R Shteinman, Sameera Ansar, et al.
The American Journal of Surgical Pathology|November 20, 2019
Molecular Profiling of Noncoding Mutations Distinguishes Nevoid Melanomas From Mitotically Active Nevi in PregnancyLouise A Jackett, Andrew J Colebatch, Robert V Rawson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 26, 2015
Tumor PD-L1 expression, immune cell correlates and PD-1+ lymphocytes in sentinel lymph node melanoma metastasesHojabr Kakavand, Ricardo E Vilain, James S Wilmott, et al.
The American Journal of Surgical Pathology|December 17, 2013
Intrapatient homogeneity of BRAFV600E expression in melanomaAlexander M Menzies, Trina Lum, James S Wilmott, et al.
Pathology|March 12, 2014
Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomasHojabr Kakavand, Oana Crainic, Trina Lum, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 4, 2015
Expression of the class 1 histone deacetylases HDAC8 and 3 are associated with improved survival of patients with metastatic melanomaJames S Wilmott, Andrew J Colebatch, Hojabr Kakavand, et al.
The American Journal of Surgical Pathology|October 3, 2012
Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanomaGeorgina V Long, James S Wilmott, David Capper, et al.
Pageof 17